logo
Select company
Select metric
13.8Interest Coverage
VS
Market
87
Sector
93
Industry
95
History
100
$ 29.46Close
$ 13.63 - $ 41.99 52-Week Range
Ticker Information

Ticker

RIGL

Company Name

RIGEL PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

RIGEL PHARMACEUTICALS INC - Interest Coverage Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RIGL - Int. Coverage Historical data
DateEarning Before Interest & Taxes (EBIT)Interest ExpenseInterest Coverage
6/30/2025$ 106.88M$ 7.74M13.8
3/31/2025$ 46.02M$ 7.9M5.83
12/31/2024$ 26.28M$ 7.92M3.32
9/30/2024$ 11.75M$ 7.87M1.49
6/30/2024$ -6.52M$ 7.71M-0.85
3/31/2024$ -12.26M$ 7.54M-1.63
12/31/2023$ -18.22M$ 6.87M-2.65
9/30/2023$ -18.36M$ 6.07M-3.02
6/30/2023$ -32.77M$ 5M-6.56
3/31/2023$ -40.96M$ 3.71M-11.05
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • RIGEL PHARMACEUTICALS INC's latest trailing twelve months (TTM) Int. Coverage stands at -21.15.
  • Over the past 5 years, RIGEL PHARMACEUTICALS INC's average Int. Coverage has been -6.11.
  • The median Int. Coverage for RIGEL PHARMACEUTICALS INC during this period was -2.84
  • RIGEL PHARMACEUTICALS INC reached its highest Int. Coverage over the past 5 years at 13.8.
  • The lowest Int. Coverage recorded by RIGEL PHARMACEUTICALS INC in the same timeframe -21.15

RIGEL PHARMACEUTICALS INC's Int. Coverage vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Int. Coverage Benchmarks
CompanyInt. Coverage
MRVI : MARAVAI LIFESCIENCES HOLDINGS INC -4.16KROS : KEROS THERAPEUTICS INC -ARVN : ARVINAS INC -RGNX : REGENXBIO INC -4.89VNDA : VANDA PHARMACEUTICALS INC -CTMX : CYTOMX THERAPEUTICS INC -XNCR : XENCOR INC -3.9ESPR : ESPERION THERAPEUTICS INC -0.46NKTR : NEKTAR THERAPEUTICS -3.62PBYI : PUMA BIOTECHNOLOGY INC 5.34

Definition of Interest Coverage

[Calculation] The Interest Coverage Ratio is a debt and profitability ratio that describes how easily a business can pay interest on its outstanding [Debt]. It is calculated by dividing the company’s earnings before interest and taxes [EBIT] by its interest expenses [IntExp].
EBIT / Int. Exp.
(=) Int. Coverage
Int. Coverage for RIGEL PHARMACEUTICALS INC is calculated as follows: EBIT [ $ -26.46M ] / Int. Exp. [ $ 1.25M ]
(=) Int. Coverage [ -21.15 ]

RIGL - Interest Coverage, Last 5 years

-21.15

Minimum

Sep 30, 2020

13.8

Maximum

Jun 30, 2025

-6.11

Average

-2.84

Median

Int. Coverage Benchmark Analysis

The chart above depicts the distribution of Int. Coverage for companies in the Total Stock Market. The average Int. Coverage of the companies is 2.16 with a standard deviation of 8.45.
The following table provides additional summary stats:
Int. Coverage in the Market:
filtered constituents2.37K
min-25.49
max28.75
average2.16
median2.09
std8.45